In the lead up to our 2022 Pharma Data & SmartLabs Congress taking place this September, we sat down with Maya Natarajan, Senior Director Knowledge Graphs at Neo4j. Being a key player within the field, Maya gave us insights into the pioneering work Neo4j is doing with knowledge graphs and the types of graph analytics that Neo4J provides.

The grant could open the door to new oral contraceptive medication for men and prevent unwanted pregnancy.

With every new technological innovation, the pharmaceutical industry moves closer to the broader introduction of automation in production lines. But what bumps in the road to progress need to be smoothed out when it comes to the standardisation of industry approaches?

This November, our PharmaTec Series discussion group focused on mobile robotics. We explored their current uses, challenges and potential.

Benedict Cross, Chief Technology Officer at PhoreMost, leads our Discussion Group on Target-Based Drug Discovery using Genomic and CRISPR techniques.

Eisai and Biogen have shared the data from a phase III trial of their joint effort Alzheimer’s drug, lecanemab

With the automation of cleanrooms set to continue for the foreseeable future, considering best practice approaches for integrating mobile robotics in a pharma-compliant manner will be key for addressing the needs of the industry. This Insight article explores some of the potential obstacles to the adoption of mobile robotics and considers how they could be addressed.

Target deconvolution is crucial to the phenotypic discovery process. Jenny Mattsson of BioInvent International explains how using CRISPR/Cas9 screening is a more efficient target deconvolution approach.

A UF Scripps Biomedical Research team have developed an RNA-targeting blood-brain penetrant small molecule to tackle genetic cases of ALS and dementia.

Key opinion leaders from AbbVie, Genentech, and the University of Southampton ask, “how and why must we change the way we work with data?”

Moderna will partner with IBM to deploy next-generation technologies such as quantum computing to optimise mRNA medicines.

Find out what you can't miss at Discovery US: In Person 2022...